KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Net Cash Flow (2016 - 2025)

Tenet Healthcare's Net Cash Flow history spans 17 years, with the latest figure at -$92.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 91.44% year-over-year to -$92.0 million; the TTM value through Dec 2025 reached -$136.0 million, down 107.59%, while the annual FY2025 figure was -$136.0 million, 107.59% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$92.0 million at Tenet Healthcare, down from $350.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $1.3 billion in Q1 2024 and bottomed at -$1.1 billion in Q4 2024.
  • The 5-year median for Net Cash Flow is $16.5 million (2021), against an average of $21.8 million.
  • The largest YoY upside for Net Cash Flow was 1461.96% in 2024 against a maximum downside of 717.82% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $72.0 million in 2021, then crashed by 586.11% to -$350.0 million in 2022, then soared by 149.71% to $174.0 million in 2023, then tumbled by 717.82% to -$1.1 billion in 2024, then surged by 91.44% to -$92.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Net Cash Flow are -$92.0 million (Q4 2025), $350.0 million (Q3 2025), and -$374.0 million (Q2 2025).